Cargando…
Hybrid Silica-Coated PLGA Nanoparticles for Enhanced Enzyme-Based Therapeutics
Some cancer cells rely heavily on non-essential biomolecules for survival, growth, and proliferation. Enzyme based therapeutics can eliminate these biomolecules, thus specifically targeting neoplastic cells; however, enzyme therapeutics are susceptible to immune clearance, exhibit short half-lives,...
Autores principales: | Gustafson, Kyle T., Mokhtari, Negin, Manalo, Elise C., Montoya Mira, Jose, Gower, Austin, Yeh, Ya-San, Vaidyanathan, Mukanth, Esener, Sadik C., Fischer, Jared M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866096/ https://www.ncbi.nlm.nih.gov/pubmed/36678770 http://dx.doi.org/10.3390/pharmaceutics15010143 |
Ejemplares similares
-
Gas-Stabilizing Sub-100 nm
Mesoporous Silica Nanoparticles for Ultrasound Theranostics
por: Montoya Mira, Jose, et al.
Publicado: (2020) -
Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device
por: Montoya Mira, Jose, et al.
Publicado: (2021) -
Preparation of PLGA-Coated Porous Silica Nanofibers for Drug Release
por: Zhang, Meina, et al.
Publicado: (2022) -
Characterization of a Sandwich PLGA-Gallic Acid-PLGA Coating on Mg Alloy ZK60 for Bioresorbable Coronary Artery Stents
por: Lin, Li-Han, et al.
Publicado: (2020) -
Dual-Porosity Hollow Nanoparticles for the Immunoprotection
and Delivery of Nonhuman Enzymes
por: Ortac, Inanc, et al.
Publicado: (2014)